Organovo Holdings Company
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.
%20.jpg)
Industry:
PharmTech
Investors Number:
2
Technology:
Others
Last Funding Type:
Series E
Headquarters:
San Diego, California, United States
Founded Date:
2007
Funding Status:
IPO
Total Funding:
$117.4M
Estimated Revenue:
$1M to $10M
Employee Number:
51-100